AC Immune Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | AC Immune

AC Immune S.A. | Mutual Funds

Mutual Funds that own AC Immune S.A.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Fidelity Select Health Care Portfolio

1,026,150

1.52%

26,150

0.13%

07/31/2018

Fidelity Select Biotechnology Portfolio

782,516

1.15%

128,527

0.08%

07/31/2018

729,149

1.08%

0.45%

07/31/2018

Fidelity Blue Chip Growth Fund

728,983

1.08%

18,577

0.02%

07/31/2018

Pictet - Biotech

642,914

0.95%

19,686

0.38%

03/31/2018

608,195

0.9%

2,536

0.48%

06/30/2018

Fidelity Advisor Health Care Fund

410,460

0.61%

10,460

0.11%

07/31/2018

Fidelity Health Care Central Investment Portfolio

372,000

0.55%

0.11%

03/31/2018

Fidelity Special Situations Fund

234,043

0.35%

-320,718

0.12%

07/31/2018

Fidelity Series Blue Chip Growth Fund

223,136

0.33%

5,686

0.03%

07/31/2018

About AC Immune

View Profile

Address	EPFL Innovation Park Lausanne Basel-Landschaft (Basle Country) 1015 Switzerland
Employees	-
Website	http://www.acimmune.com
Updated	07/08/2019
AC Immune SA is a clinical stage biopharmaceutical company, which engages in developing therapeutic and diagnostic products. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, and Andrea Pfeifer on February 13, 2003 and is headquartered in Lausanne, Switzerland.